Journal of Cystic Fibrosis

Title Publication Date Language Citations
Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study2014/12/01English95
Hyperpolarized 129Xe for investigation of mild cystic fibrosis lung disease in pediatric patients2017/03/01English95
Infection and inflammation in cystic fibrosis: A short review2005/08/01English94
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis2012/07/01English92
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)2019/11/01English91
Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis2016/05/01English91
Treatment compliance in children and adults with Cystic Fibrosis2008/09/01English91
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients2013/09/01English90
Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease2020/05/01English90
Year-to-year changes in lung function in individuals with cystic fibrosis2010/07/01English89
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia2015/01/01English89
The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe2017/03/01English89
Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota2013/05/01English89
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis2013/05/01English88
Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment2016/03/01English87
Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients2014/07/01English87
Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults2004/06/01English87
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis2012/09/01English86
Transepithelial electrical measurements with the Ussing chamber2004/08/01English86
Clinical importance of cystic fibrosis-related diabetes2004/12/01English85
Cytokines and inflammatory mediators in cystic fibrosis2004/12/01English84
Alveolar inflammation in cystic fibrosis2010/05/01English84
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response2012/12/01English84
A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis2009/01/01English84
Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study2006/12/01English83
Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher2017/05/01English82
Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis2019/10/01English81
Peripheral muscle abnormalities in cystic fibrosis: Etiology, clinical implications and response to therapeutic interventions2017/09/01English79
Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF2010/12/01English79
Patient-reported respiratory symptoms in cystic fibrosis2009/07/01English79